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Background: Tuberculous pleurisy is a kind of tuberculosis, it is well known that Th1 lymphocytes play a key role
in the treatment of tuberculosis infection. However, latest studies show that Th17 lymphocyte may also play an
important role tuberculosis infection. There is close relationship between Treg and Thl7 cells, and changes in the
number or the function of the two kinds of cells may lead to diseases. The current researches on Thl7 and Treg
cells maily focus on autoimmune diseases, however, reports about their role in tuberculosis are limited. In this
study, we investigate the function of th17 and Treg cells and the above cytokines in the pathogenesis of
tuberculosis pleurisy; by determining the expression of Th17 and Treg cells in peripheral CD4 T cells and the
related cytokines in patients with tuberculous compared with healthy people.
Results: Th17 cells in patients were higher than that in the Healthy control group, expression of Treg cells in
patients were lower than that in the healthy group; IL-17, IL-23 levels in peripheral blood and hydrothorax from the
patients were higher than that in the healthy group; IL-17, IL-23 and IL-6 levels in hydrothorax were higher than
that in peripheral blood. There was no difference in IL-6 level in peripheral blood between the patients and healthy
control; TGF- β level in peripheral blood from the healthy group was higher than that in peripheral blood and
hydrothorax from the patients. And there were no differences in TGF- β level between peripheral blood and
hydrothorax. Th17 cells were negatively correlated with Treg cells ,but were positive correlation with IL-17, IL-23,
IL-6 levels in peripheral blood; TGF- β level was positive correlation with Treg cells in the peripheral blood, but no
correlation with Th17 cells.
Conclusion: Th17 and Treg cells may be involved in the immune pathological mechanism of tuberculous pleurisy
and changes of related cytokines may be involved in the differentiation of Th17 and Treg cells and inflammatory
response. Thus, Th17 and Treg cells and related cytokines may be important immunopathogenesis for tuberculous
pleurisy.
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Tuberculosis is one of the most important infectious
diseases worldwide [1]. In China, tuberculosis also poses
a very serious threat to health [2]. Tuberculous pleurisy
is a kind of tuberculosis. It is believed that Th1 lympho-
cytes play a key role in the treatment of tuberculosis in-
fection [3,4]. Aside from Th1 lymphocytes, latest studies
have shown that Th17 lymphocyte may also play a very* Correspondence: wzhxx128@163.com
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[5,6]. Th17 cells are a type of immune cells discovered
in recent years. They are CD4 + T lymphocyte subsets,
which are different from the Thl and Th2 immuno-
reactive cells. Thl7 and Treg cells are closely related with
each other. Though they are functionally antagonistic,
they are correlated during the process of differentiation.
Changes in the number or in the function of the two
kinds of cells may lead to diseases. The current research
on Thl7 and Treg cells was more or less concentrated
on autoimmune diseases. Rarely is seen the reports
about their role in tuberculosis. Among the limitedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Expression of Th17 cells and Treg cells in
peripheral blood in control and patient groups
Groups Cases Th17cell (%) Tregcell (%) Th17cell/Tregcell
Control 34 0.89 ± 0.13 5.10 ± 0. 90 0.17 ± 0.05
Tuberculous
pleurisy
35 1.02 ± 0.20 4.64 ± 0.77 0.25 ± 0.07
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Thl7 cells and Treg cells in tuberculosis do not agree with
each other, which we will discuss in detail in the discus-
sion part. For the above reasons, we detected Th17 and
Treg cells and the related cytokines in patients with tuber-
culous pleurisy and those in the healthy to investigate the
roles of Th17 and Treg cells and the related cytokines in
immunopathogenesis of tuberculous pleurisy.
Materials and methods
Subjects
All subjects are outpatients without drug treatment in the
Tuberculosis Department of the First Affiliated Hospital
of XinXiang Medical University from January 2011 to
December 2012 (this experimental research is approval of
the ethics committee of Xinxiang medical university), 34
healthy cases were used as the control group, with mean
age 33.6 ± 8.7 years old. Among them, 24 were males and
10 were females. 35 tuberculous pleurisy cases were used
as the experimental group, mean age 30 ± 7.8 years old.
26 of them were males and 9 were females. The above tu-
berculosis cases were in line with China’s TB diagnosis
standard, while physical examination showed that there
were no other pathogen infections and autoimmune
diseases in them.
Experimental method
6 ml of blood was collected from the veins of each case
in both the experimental and the control groups. Blood
was divided into two tubes, 3 ml in each tube. One tube
is for the detection of Thl7 and Treg cells by flow cy-
tometry. The other tube was for quantitative detection
of IL-17, IL-23, IL-6, TGF- β factor. 5 ml of hydrothorax
were extracted from all the patients for quantitative
detection of IL-17, IL-23, IL-6, TGF- β factor by ELSIA
method. The operation was in strict accordance with the
instructions.
Instruments and reagents
Instruments: the flow cytometry was from BD company
(FACS Canto) in USA. The enzyme immunoassay in-
strument was from the Aidekang Company in Yantai,
Shandong Province, China; Reagents: Thl7 and Treg kits
were from Biolegend company. Thl7 kits include FITC
labeled anti human CD3, PE labeled anti human CD4,
Alexa 647 Fluor markers anti human IL-7 and the
matched rat IgGl isotype control, stationary liquid and
membrane rupture lotion. And the Treg kits include
FITC labeled anti human CD4, PE labeled anti human
CD25, Alexa Fluor647 FOXP3 and the matched rat IgGl
isotype control, Foxp + 3 fixed/rupture of membrane
liquid and rupture of membrane buffer. Phorbol ester
and anionomycin were purchased from Sigma company.
Mo can mycin was purchased from Biolegend company.IL-17 kit was from Biosource company. IL-23 kit was
from Bender Medsestems Company. IL-6 and TGF- β
kit were from Xinbosheng Biological Technology Co. in
China.
Statistical analyses
Data were analyzed by SPSS17.0 statistical software. All
data were indicated as means and standard deviations
(x ± s). The statistic difference among means of experi-
mental data were measured by independent sample T
test and paired data T test, and correlation analysis was
carried out by Pearson correlation analysis. And P < 0.05
is regarded as statistically significant.
Declaration: the involved patients in the research have
agreed to publish manuscript.
Results
Expression of Th17 and Treg cells in CD4+ Tcells in
peripheral blood
The percentage of Th17expression in CD4+ cells were
0.89 ± 0.13% in control group and 1.02 ± 0.20% in the
experimental group. The expression of Th17 cells in
patients group was significantly higher than in the
control group, P < 0.05. Expression ratios of Treg cell
were 5.10 ± 0.90% in control group and 4.64 ± 0.77% in
patient group. The ratio of Treg cells in control group
was significantly higher than that in patient group, P <
0.05. The ratio of Th17/Treg cells in patient group was
significantly higher than in the control group, P < 0.05
(Table 1). FCM pictures of Th17 and Treg cells in CD4+
cells in peripheral blood were shown in Figure 1, and
distribution pictures of expression of Th17 and Treg
cells in CD4+ cell in peripheral blood were shown in
Figure 2.
Change of cytokines level in patients with tuberculous
pleurisy
IL-17 and IL-23 levels in peripheral blood from patients
with tuberculous pleurisy were significantlyhigher than
those from the healthy, the P values being 0.022 and
0.039 (the independent sample T test). IL-17 and IL-23
levels in hydrothorax from were significantly higher than
that in the blood from the patients (paired data T test),
with the P =0.000 and 0.000; IL-6 level in hydrothorax
from the patients was significantly higher than that in
Figure 1 Flow cytometry pictures of Th17 and Treg cells.
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the blood from the healthy (independent samples T test),
P =0.003 and 0.000. There was no difference in IL-6
level between blood from patient and that from the
healthy (independent samples T test, p = 0.274). TGF-
βconcentration in peripheral blood from the healthy was
significantly higher than in peripheral blood and hydro-
thorax from the patients (independent samples T test),
with =0.005 and 0.000 respectively. There was no signifi-
cant difference between TGF- β level in blood and in
hydrothorax from the patients, p = 0.365 (paired data T
test) (Table 2). The cytokine level distribution was
shown in Figure 3 (Notes: 1: The cytokines in peripheral
blood from the healthy; 2: the cytokines in peripheral
blood from the patients; 3: cytokines in hydrothorax
from the patients).Figure 2 Distribution pictures of expression of Th17 and Treg cells (n
expression ratios of cells; the ordinate: frequency of Corresponding rThe correlation among Th17 and Treg cells and cytokines
in peripheral blood
Th17 cells and IL-17, IL-23, IL-6 were positively corre-
lated, P < 0.05. But there was no significant correlation
between Th17 cells and TGF-β level, P > 0.05. Treg cells
and IL-17, IL-23 were of significant negative correlation.
There was a significant positive correlation between
Treg cells and TGF- β, P < 0.05 (Table 3).
Discussion
Th17 cells are a type of immune cells found in recent
years. They are CD4 + T cell subsets with strong pro-
inflammatory effect,but they differ from Thl and Th2
immune cells [7]. Thl7 cells and Treg cells are closely
related to each other. Though functionally antagonistic,
they are correlated in the process of differentiation.
Changes in their number or in their ways of functioning
can lead to the disease. The current research on Thl7
cells and Treg cells is more concentrated on their roles
in autoimmune diseases, but their roles in tuberculosis
germination and development remain unclear [8,9].
Recently, it is believed that Th1 cells and IFN- γ play a
very important role in the protective immunoreaction
against tuberculosis [3,4]. But besides Th1 cells, other
immune cells and cytokines could also be important for
fighting against tuberculosis [5,6,8]. So we designed the
study to explore roles of Thl7 and Treg cells and the
related cytokines in pathogenesis of tuberculosis. In this
study, Thl7 cells from patients with tuberculous pleurisy
were significantly higher than from the healthy, but Treg
cells were lower than from the healthy, and the ratios of
Thl7/Treg from patients were significantly higher than
from the healthy, which showed immune imbalance
between Th17 cells and Treg cells from the patients.
The imbalance may play an important role in the patho-
genesis of tuberculosis.At present, the roles of Thl7 and
Treg cells in tuberculosis were rarelyreported. Even
when reported, views varied greatly from researcher to
researcher. Previous reports showed that Thl7 cells fromotes: 1. the control group 2. the patient group. The abscissa:
atios).
Table 2 Cytokines level in periphery blood from the healthy and the patients and hydrothorax from the patients
Group Cases IL-17 IL-6
Peripheral blood Hydrothorax Peripheral blood Hydrothorax
Control 34 14.45 ± 3.81 4.26 ± 0.91
Tuberculous pleurisy 35 17.49 ± 3.94 26.13 ± 5.98 4.54 ± 1.02 5.31 ± 0.74
Group Cases IL-23 TGF-β
Peripheral blood Hydrothorax Peripheral blood Hydrothorax
Control 34 77.55 ± 20.26 3.95 ± 0.79
Tuberculous pleurisy 35 90.42 ± 23.06 122.26 ± 31.71 3.32 ± 0.80 3.12 ± 0.77
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the healthy [5,6,10], and that Treg cells were significantly
lower than those from the healthy [10], which was in
line with our results. But others reported contradictory
research results [1,11]. Some showed that the expression
ratio of Thl7 cells in tuberculosis patients didn’t vary
significantly from those in the healthy [12], or it was
even lower than in the healthy when accompanied by
less expression of IL-6R of CD4 + T cells [13]. Th17 cells
were considered to be one of the most important cells to
mediate inflammation and autoimmunity action [14],
and played important roles in autoimmune diseases, in
fighting against extracellular bacteria infection, in medi-
ating chronic inflammation and tumor. Thl7 cells mainly
secreted IL-17A, IL-17 F, IL-6 and tumor necrosis factor
(TumorNecrosis, factor, TNF) - α, IL-21, IL-22, and
macrophage colony stimulating factor (granulocyte –Figure 3 Frequency of various cytokines level in peripheral blood and
healthy; 2. cytokines level in blood from the patients; 3. cytokines lev
the ordinate: frequency of corresponding cytokines).macrophage colony -stimulating factor, GM-CSF). Treg
cells were a kind of CD4 + T cells with specific expres-
sion of transcription factor Foxp3 and negative immune
regulatory function. They could exert anti-inflammatory
effects or maintain auto-immune tolerance by contact
inhibition of cells and by secreting inhibitory cytokines,
such as lL-10 and TGF- β. Thl7 cells were closely related
with Treg cells. Both were differentiated from natural
CD4 + T cells, and were related and diversionary in their
differentiation and function [15]. In the present study,
Th17 cells from untreated patients with tuberculosis
pleurisy were significantly increased, while Treg cells
decreased, which showed that the unbalance between
Th17 and Treg cells played an important role in immu-
nopathogenesis of tuberculous pleurisy. But why there
was inconsistency between our research and previous re-
ports? We think the following factors may be important:hydrothorax (notes: 1. cytokines level in blood from the
el in hydrothorax from the patients. The abscissa: cytokines level;
Table 3 The correlation among Th17 and Treg cells and
cytokines in peripheral blood
Immune cell Th17cell Tregcell
Cytokines r p r p
IL-17 0.479 0.013 −0.356 0.016
IL-23 0.441 0.015 −0.318 0.019
IL-6 0.326 0.017 0.152 0.089
TGF-β 0.091 0.659 0.297 0.024
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subjects may play a part in the inconsistency; 2. Diffe-
rent sampling time may also be an important factor.
Sampling from subjects may happen before treatment,
after treatment or during treatment, which could also
lead to the discrepancy in results; 3. Choice of different
experimental methods also had certain influence on the
results. IL-23 is an important cytokine that takes part in
differentiation of Th17 cells [16,17]. It is not the initi-
ation factor of Th17 cell differentiation, but it is an
important survival factor of Th17 cell. IL-23 was pro-
duced by macrophages enabled by antigen in the process
of inflammation [18]. In the present study, IL-23 level in
peripheral blood and hydrothorax from the patients was
significantly higher than in peripheral blood from the
healthy, and there was a positive correlation between
IL-23 level and Th17 cells level in peripheral blood,
which shows that IL-23 plays a role in the increase of
Th17 cells.
Th17 cells produced a cytokine, IL-17. By combining
with IL-17 receptors on epithelial cells, endothelial cells,
and fibroblasts, IL-17 could activate MAP kinase and NF-
kB so that they could exert their biological activity [15],
which enabled these cells to produce a series of cytokines
to guide leukocytes to gather at the infectious part where
these leukocytes became mature and activated, and released
lysosomal enzymes that could cause injury to endothelial
cells and relating tissues, thus aggravating inflammation.
IL-17 could also lead to macrophage accumulation in in-
flamed areas. These macrophages were activated by bacteria
and the toxins produced by bacteria. The activated macro-
phages were involved in inflammation and immune
response, and produced IL-6, IL-1, TNF-a, and IL-23,
which enhanced local inflammation. The produced IL-23
promoted the differentiation of Th17 cells and helped
maintain Th17 cells at a high level. The elevated Th17 cells
produced more IL-17 which aggravated inflammation reac-
tion. In this study, Th17 cells were significantly positively
correlated to IL-17 level in peripheral blood and hydro-
thorax from the patients, which confirmed that IL-17 was
produced by Th17 cells. Although IL-23 and IL-17 showed
a positive correlation with Th17 cells, they were signifi-
cantly negatively correlated with Treg cells. The negative
relation might indicate that IL-23 and IL-17 inhibited Tregcells, and some previous researches indicated that IL-23
and IL-17 could inhibit the function of Treg cells [19,20].
But we found no theoretical basis to support that idea. IL-6
is a cytokine secreted by Th17 cells. In this study, IL-6
levels in peripheral blood and hydrothorax from the
patients were significantly higher than in peripheral blood
from the healthy. There was a significant positive corre-
lation between IL-6 levels and Th17 cells, but no significant
correlation between IL-6 levels and Treg cells. TGF-β is a
cytokine secreted by Treg cells. In this study, there was no
significant correlation between TGF-β and TH17cells in
peripheral blood, and there was a significant positive corre-
lation between TGF-β and Treg cells in peripheral blood.
TGF-β in peripheral blood from the healthy was higher
than in peripheral blood and hydrothorax from the
patients, which showed that TGF-β was from Treg cells.
Research showed that IL-6 was a key factor connecting
Th17 and Treg cells [21]. When TGF- β alone was stimu-
lated activated CD4+ cells, the activated CD4 + cells differ-
entiated into Treg cells. But when TGF-β and IL-6 were
stimulated together, the activated CD4 + cells would diffe-
rentiate into TH17 cells [22]. Based on the above evidence,
it could be concluded that Th17 cells would further
increase because of the high level of IL-6 with a certain
concentration of TGF- β in inflammation part, therefore
increasing the inflammation reaction of patients.
In summary, the unbalance between Th17 and Treg
cells played an important role in the immune patho-
logical injury of patients with tuberculous pleurisy.
Excess IL-17, IL-6, and IL-23 in inflammation part further
increased the number of Th17 cells. Increased Th17 cells
secreted large amounts of inflammatory cytokines. Then
these inflammatory cytokines increased inflammatory
reaction of inflammatory part. So the unbalance between
TH17 and Treg cells and the inflammatory cytokines
secreted by TH17 and Treg cells play important roles in
the immune pathological reaction of patient with tubercu-
lous pleurisy. The research results may provide a theory
support for the treatment of tuberculous pleurisy.
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